Immunotherapy is showing great promise for treating cancer. But so far, this approach has been effective in only about 20% of all cancers. To advance those results, researchers are looking for new ways to mobilize the immune system to destroy tumors.
Most immunotherapy drugs act on one type of immune cells called T cells. Drugs called checkpoint inhibitors “release the brakes” on these cells, spurring them to mount an attack against a tumor. Read more . . .